Sanae Reggoug
Al Garhoud Private Hospital, UAE
Title: PPIs long term safety. What should we know as clinicians? What should we tell our patients?
Biography
Biography: Sanae Reggoug
Abstract
Proton pump inhibitors (PPI) are amongst the most commonly prescribed medications worldwide. Long term use of PPI is indicated in some clinical situations such as severe gastroesophageal reflux disease and prophylaxis purpose in patients using non-steroidal anti-inflammatory drugs.
PPIS safety profile was considered very good till recent years. A systematic medical literature search through Pubmed, using keywords PPI, safety, long term and risk, revealed not less than 300 publications related to PPI safety since the beginning of year 2017. These medical publications received considerable attention from media and strongly affected not only patient’s therapeutic compliance but also prescribers practice.
During this evidence-based presentation, the safety of long term use of PPIs will be examined and guidance will be provided on what clinicians need to know and what to tell their patients. A critical and objective analysis of the studies on PPIs safety will be demonstrated, highlighting epidemiological limitations and methodological concerns.